7
Implementing Recommended Changes

An enhanced role is envisioned for the NHQR and NHDR in helping drive health care quality improvement for the nation. The NHQR and NHDR can provide a valuable context and a potential focus for the hundreds of thousands of independent quality improvement activities occurring across the nation. The reports alone cannot generate improvement in the quality of U.S. health care, but they can clearly present compelling information that identifies gaps in care, describes the progress of the nation in closing those gaps, sets a direction for investments in improvement, and identifies evidence-based policies and practices that can assist in achieving higher quality and equitable care. The changes that the Future Directions committee envisions for the NHQR, NHDR, and associated products will require additional resources for the Agency for Healthcare Research and Quality.

Throughout this report, the IOM Future Directions committee has recommended changes in the content and presentation of the NHQR and NHDR. These changes are intended to make the reports more forward-looking and action-oriented by engaging national and state policy makers and other stakeholders in the quest to improve health care quality for the nation. The redesigned NHQR, NHDR, and their related products would continue to fulfill the congressional mandate to report on trends and prevailing disparities, but the focus would be more on driving improvement.1

Despite the considerable strengths of the national healthcare reports, the committee assessed them as lacking:

  • a clear set of national priorities on which to focus quality measurement and highlight, through the presentation of data, how policies and practices support achievement of these priorities;

  • an affirmation in both the NHQR and NHDR that achieving equity is an essential part of quality improvement;

  • an assessment of which measurement areas could have the greatest impact if gaps between current and recommended levels of performance were closed;

1

Health Research and Quality Act of 1999, Public Law 106-129 § 902, 913, 106th Congress, 1st sess. (December 6, 1999).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 137
7 Implementing Recommended Changes An enhanced role is enisioned for the NHQR and NHDR in helping drie health care quality improe- ment for the nation. The NHQR and NHDR can proide a aluable context and a potential focus for the hundreds of thousands of independent quality improement actiities occurring across the nation. The reports alone cannot generate improement in the quality of U.S. health care, but they can clearly present compelling information that identifies gaps in care, describes the progress of the nation in closing those gaps, sets a direction for inestments in improement, and identifies eidence-based policies and practices that can assist in achieing higher quality and equitable care. The changes that the Future Directions committee enisions for the NHQR, NHDR, and associated products will require additional resources for the Agency for Healthcare Research and Quality. Throughout this report, the IOM Future Directions committee has recommended changes in the content and presentation of the NHQR and NHDR. These changes are intended to make the reports more forward-looking and action-oriented by engaging national and state policy makers and other stakeholders in the quest to improve health care quality for the nation. The redesigned NHQR, NHDR, and their related products would continue to fulfill the congressional mandate to report on trends and prevailing disparities, but the focus would be more on driving improvement.1 Despite the considerable strengths of the national healthcare reports, the committee assessed them as lacking: • a clear set of national priorities on which to focus quality measurement and highlight, through the presenta - tion of data, how policies and practices support achievement of these priorities; • an affirmation in both the NHQR and NHDR that achieving equity is an essential part of quality improvement; • an assessment of which measurement areas could have the greatest impact if gaps between current and recommended levels of performance were closed; 1 Health Research and Quality Act of , Public Law 106-129 § 902, 913, 106th Congress, 1st sess. (December 6, 1999). 

OCR for page 137
 NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORTS • identification of important measurement and data gaps to set a research and data collection agenda; 2 and • best-in-class benchmarks that show the gap between current average performance and the best attained performance. Overall, the presentation in the reports needs to tell a more complete quality improvement story. In previous chapters, the Future Directions committee has recommended a number of steps to address these issues. Specifically, the committee suggests a set of national priority areas for quality improvement and dispari - ties, and recommends that AHRQ ensure the NHQR and NHDR report on progress made toward these national priorities (Chapter 2). AHRQ should more closely align future iterations of the NHQR and NHDR to ensure a focus on equity in the NHQR; the relationship between quality and equity is underscored in the updated quality framework, which includes equity and value as crosscutting components (Chapter 3). Moreover, the committee recommends the use of a more quantitative and transparent process for ranking performance measures for use in the NHQR and NHDR and for documenting measurement and data gaps (Chapter 4). New data sources, including subnational ones, may be appropriate for inclusion in future national reports. Furthermore, to ensure the ability to measure and compare quality across all population groups, standardized data on race, ethnicity, and language need, as well as other sociodemographic descriptors, must be collected and analyzed (Chapter 5). Finally, the committee recommends that the current emphasis in the NHQR on comparing quality data to average national performance be modified so that greater emphasis is placed on outcomes that have been previously attained by health care providers, health care organizations, or states (i.e., best-in-class benchmark) (Chapter 6). Performance gaps have been repeatedly documented by the national healthcare reports and other quality reporting entities. The Future Directions committee supports the broader dissemination of re-designed reports and associated products to spur the engagement of actors across the U.S. health care system in affecting substantial and accelerated progress on national priority areas. Change, however, will require a broad national commitment and engagement. Impetus for action, complementary to the reports, should come from a combination of federal and state leadership with broad stakeholder consensus on national priorities, from leadership and direction by public and private sector entities (particularly insurers and employers), and from the commitment of resources that aim to remove barriers to improving the quality of U.S. health care. RESOURCES REQUIRED TO IMPLEMENT RECOMMENDATIONS The statement of task for the Future Directions committee (see Chapter 1) specifically asked that the com - mittee “take note of recommendations that are estimated to be a reach for the current resources of AHRQ” (IOM, 2008). The committee acknowledges that implementing most elements of the recommendations presented in this report will require additional funding. Investing in National Quality Measurement Efforts When considering the need for AHRQ to receive additional funding to implement the committee’s recom - mendations, the committee used existing and expected health care spending and recent recommendations for funding quality measurement enterprises as a context for understanding the necessary degree of investment. With $2.3 trillion spent on U.S. health care in 2008, health care expenditures constitute more than 16 percent of the U.S. gross domestic product (GDP) (CMS, 2010; Cutler, 2009). Moreover, health care spending is projected to comprise 20 percent of the country’s GDP by 2017 (Keehan et al., 2008) and up to 40 percent of the GDP by 2050 (CBO, 2007). A number of proposals—elements of which are similar to activities proposed by the Future Directions committee—have estimated funding needed to enhance the nation’s quality improvement infrastructure. For example, 2 The 2008 NHDR lists the population groups (e.g., Asian or Pacific Islander, American Indian/Alaska Native, and poor) for which data are not available for its core measures (p. 287).

OCR for page 137
 IMPLEMENTING RECOMMENDED CHANGES • The 2006 IOM report Performance Measurement: Accelerating Improement (IOM, 2006) recommended the formation of a National Quality Coordination Board with a budget of $100-$200 million. 3 This estimate constituted approximately 0.1 percent of the Medicare budget at the time. • In 2009, the organization Stand for Quality—supported by 165 organizations coalescing around the issues of setting national priorities, making “performance information available and actionable,” and supporting a “sustainable infrastructure for quality improvement”—estimated that $300 million is needed for each of the next 3 years4 (Stand for Quality, 2009). • Under the authority of the Medicare Improements for Patients and Proiders Act of 00, HHS awarded $10 million over each of the next several years to the National Quality Forum (NQF) to identify the most important quality and efficiency measures that would reflect the high cost of chronic disease and the con - tinuum of care across settings for those cared for under Medicare (NQF, 2009). 5 • A national health reform bill passed by the U.S. House of Representatives in November 2009 called for $4 million per year from fiscal years 2010 through 2014 for health care priority setting by the HHS Secretary; $50 million per year from fiscal years 2010 through 2014 for health care quality measure development; and $12 million per year from fiscal years 2010 through 2012 for a consensus-based entity to ensure multi- stakeholder input for measure development specific to public reporting and public health care programs. 6 A national health reform bill passed by the U.S. Senate in December 2009 and that became law in March 2010 called for $75 million per year from fiscal years 2010 through 2014 for the development of new quality measures and for $20 million per year from fiscal years 2010 through 2014 for additional improvements in quality measurement.7 Congress has designated the NHQR and NHDR as the national reports on health care quality and disparities.8 Therefore, the reports are deserving of sufficient funding to ensure they have a more widespread impact on quality improvement. Additional Funding Required for AHRQ for Implementation When Congress mandated the NHQR and NHDR in 1999, it did not provide dedicated funding for the reports. Currently, the report-related effort is funded within AHRQ at an annual cost of approximately $3.7-$4.0 million. To implement the improvements recommended by the Future Directions committee, a substantial increase over current funding may be necessary. Transforming the report products, engaging national and state policy makers and other actors, strengthening performance metrics, improving data, and supporting the committee’s recommended measure selection process are important avenues for improving health care quality for the nation. The Future Directions committee is not able to determine to what extent, if at all, AHRQ might be able to reprogram funds within its existing budget to cover some implementation needs. The committee urges AHRQ to 3 The National Quality Coordination Board was conceived as an independent body housed in the Office of the Secretary with a proposed $100-$200 million budget. Its functions included specifying the purpose and aims for American health care; establishing short- and long-term national goals for improving the health care system; and identifying and funding a research agenda for the development of new measures to ad- dress gaps in performance measurement. Other functions included designating, or if necessary developing, standardized performance measures for evaluating the performance of current providers; monitoring the nation’s progress toward these goals; ensuring the creation of data collec- tion, validation, and aggregation processes; establishing public reporting methods responsive to the needs of all stakeholders; and evaluating the impact of performance measurement on pay for performance, quality improvement, public reporting, and other policy levers. 4 The major activities cited include setting national priorities and providing coordination; endorsing and maintaining national standard mea- sures; developing measures to fill gaps in priority areas; consulting with stakeholders; collecting, analyzing, and making performance infor- mation available and actionable; and supporting a sustainable infrastructure for quality improvement. The $300 million includes at least $100 million for translational research on payment models. 5 Medicare Improements for Patients and Proiders Act of 00, Public Law 110-275, 110th Cong., 2d sess. (July 15, 2008). 6 Affordable Health Care for America Act, HR 3962 § 1441, 1442, 1445, 111th Cong., 1st sess. (November 7, 2009). 7 The Senate bill was passed into law in March 2010 as the Patient Protection and Affordable Care Act (Public Law 111-148 § 3013, 3014, 111th Cong., 2d sess. (March 23, 2010)). 8 The strategic plan reporting requirement in the Patient Protection and Affordable Care Act would inform but not duplicate AHRQ’s national healthcare reports (Patient Protection and Affordable Care Act, Public Law 111-148 § 3011, 111th Cong., 2d sess. (March 23, 2010)).

OCR for page 137
0 NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORTS continue to leverage its own resources by partnering with other entities and agencies to accomplish as much of the new vision set out by the committee as possible. The committee was not tasked with making specific budgetary recommendations or estimates; therefore, the wording of the committee’s recommendation speaks to providing sufficient funds rather than a specific amount: Recommendation 9: To the extent that existing resources cannot be reallocated, or AHRQ cannot leverage its resources by partnering with other stakeholders and HHS agencies, AHRQ should work to obtain additional funds to support the work of the Technical Advisory Subcommittee for Measure Selection, the upgrades and additions to AHRQ’s national healthcare report-related products, and the development of new measures and supporting data sources. An illustrative example of how the committee’s recommended improvements might be funded is provided in Appendix I. The committee believes that given the need for health care quality improvement, an increase in funds available to AHRQ would be worthwhile, and that over time, upgrades to the NHQR and NHDR, Web-based resources, derivative products, engagement activities, prioritization analyses, measure development, and data acquisition may require specific additional funding beyond the illustrative amounts contained in Appendix I. For example, the work of the NAC Technical Advisory Subcommittee for Measure Selection will generate ideas for the development of health care quality measures or data sources for high-impact areas that would be tracked nationally; these developmental activities can be quite expensive and are not accounted for in the scenario outlined in the appendix. Upgrading the Reports and State Snapshots In calendar year 2010, with a modest increase in staffing and resources, AHRQ should be able to include numerous upgrades in the 2010 NHQR, NHDR, and State Snapshots (which would be released in early 2011) by incorporating: 1. The topic of access into the NHQR and the State Snapshots 2. Benchmarks that reflect best attained performance for each measure 3. Extrapolation of when performance levels close the current gap between current practice and the recom - mended standard of care (goal or benchmark) will be met based on historical trends 4. Recognition of the degree of variation among population groups on quality measures relative to best attained performance 5. A summary of disparities data in the NHQR and an introductory exposition of the interrelationship between quality and equity in both reports 6. A summary of performance by state in the NHQR and NHDR (not just in the State Snapshots) 7. Improved presentation (e.g., sharper key messages, identified data needs and best practices, redefined Highlights section) 8. Measures and new report sections that support the committee’s recommended set of national priority areas and new framework components (e.g., care coordination and infrastructure) 9. Fuller exposition on the specific needs of priority populations While the first six of these suggestions may be able to be accomplished within existing resources, the movement from a statistical chartbook format to one that tells a more vivid and complete story of the current status of health care quality will require revamping the current products, conceptually and analytically (e.g., not just reporting overall performance on an individual measure, but producing analyses that include, for example, findings on specific program performance, the effect of health insurance by type, or relationships among process measures and outcomes). As recommended in Chapter 6, AHRQ should consult with communication and statistical experts to hone presentation methods for broad audiences while still providing sufficient information on analytic methods for specialized users. In the near term, AHRQ can begin to add new sorting functions in the State Snapshots (see Chapter 2, Table 2-2) and begin to drill down into the datasets to provide information on substate variation for some measures. The Future

OCR for page 137
 IMPLEMENTING RECOMMENDED CHANGES Directions committee observes that there is limited treatment of priority populations in the NHDR and feels that there should be some expansion of content relevant to those populations both within the reports and via spinoff products. There will be occasions where new analyses and data acquisition will be required, whether national or subna - tional in character (e.g., multipayer databases, program-specific data). As new measures and data sources become available (e.g., data from the Centers for Medicare and Medicaid Services [CMS], data from electronic health records), the committee hopes that through collaborative partnerships, much of these data and their subsequent analyses can be supplied without charge to AHRQ as data and analysis already takes up at least half of the AHRQ report budget. Currently the NHQR and NHDR have limited reporting based on Medicare, Medicaid, and private sector data, and the committee urges AHRQ to expand these data in future editions. Upgrading Online Resources, Adding Deriatie Products, and Enhancing Dissemination The committee has recommended AHRQ directly or via contracts update the State Snapshots and the NHQRDRnet to: • Include fact sheets, topic-specific derivative products (e.g., expanded mini-reports on priority populations), and capability to customize reports to user needs. • Ensure links between the NHQR and NHDR on the same measures. • Increase the visibility of AHRQ products through a better dissemination and engagement plan (e.g., meet - ings with stakeholders including organizations representing communities of color, Web optimization, targeting fact sheet topics to specific audiences, and translating some materials into user languages). • Provide tools that show AHRQ’s analytic methods for users who want to manipulate primary datasets. • Develop the Guide to Using the NHQR and NHDR and other topic-specific derivative products. In 2010, AHRQ should determine, in conjunction with a dissemination plan, a longer term development strategy for products that have priority for development. It is unlikely that all of the fact sheets, mini-reports, and tools can be developed within one year. The committee’s recommendation for expanded dissemination activities is not considered superfluous to AHRQ’s work on the NHQR and NHDR. In fact, the committee believes it is essential to it. If the NHQR, NHDR, and related products are to serve as conduits for information that have the potential to drive change, that informa - tion needs to be properly distributed to relevant stakeholders and reflect their needs, engage them in improvement activities related to priorities and measures monitored in the reports, and assess the impact of the information and partnerships across time. Implementing a More Quantitatie and Transparent Measure Selection Process The committee has recommended that AHRQ establish an external advisory process for the selection and ranking of measures for the national reports—a Technical Advisory Subcommittee for Measure Selection within the existing structure of AHRQ’s National Advisory Council for Healthcare Research and Quality (NAC). This subcommittee should be established in calendar year 2010 to begin planning for the assessment of measures. New funds would be required to staff the subcommittee and conduct its public deliberations when prioritizing among measures to be featured in the AHRQ reports. In addition, AHRQ will need specific funds to hire staff or contract for the systematic review and analyses required to apply quantitative techniques toward assessing how much closing specific gaps in performance will benefit the overall health of the nation and that of specific priority populations. 9 9 Personal communication, Michael Maciosek, HealthPartners. January 6, 2010. Estimates for conducting these types of quantitative reviews vary depending on the depth of the literature review, experience with the methods and availability of data, options for intervention, complexity of technology being assessed, and other factors. For example, a de noo cost-effectiveness evaluation with a thorough but not necessarily sys- tematic review might cost $100,000. Reports from the Health Technology Assessment program in the United Kingdom, which tend to be very thorough, typically cost between £100,000 and £500,000 per technology assessment (see http://www.hta.ac.uk/project/htapubs.asp).

OCR for page 137
 NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORTS Funding Measure and Data Infrastructure for the NHQR and NHDR Oft-cited quality improvement axioms are, “What gets measured gets done/managed,” and “You cannot improve what you do not measure.”10 But there is a third cautionary saying: “Be careful what you measure.” In view of this latter sentiment, the committee recognizes that naming national measures of health care quality carries potential risks, because doing so can divert resources from other potentially valuable initiatives. The Future Directions committee believes it important for AHRQ to have resources to support not only the activities of the NAC Technical Advisory Subcommittee for Measure Selection in evaluating and ranking quality improvement measures for the greatest health benefit, but also to examine new evidence related to the performance measures it uses in the NHQR and NHDR and to support the evaluation of alternative or new measures and the development of data. Questions raised previously with regard to specific measures endorsed by NQF and used by The Joint Com - mission and CMS illustrate the importance of making this investment. In recent years, for example, there has been debate in the literature over whether increased adherence to a set of heart failure process measures results in improved patient outcomes (Fonarow and Peterson, 2009; Fonarow et al., 2007; Kfoury et al., 2008) and whether measures related to antibiotic timing in patients with pneumonia have unintended adverse effects (Dean, 2009; Wachter et al., 2008). AHRQ will need to partner with others to ensure that the strength of the science of measures remains high and up-to-date, but the agency may need to be able to promote and potentially fund some separate investigations. The IOM reports published in 2001 and 2002 to advise AHRQ on the NHQR and NHDR encouraged the development of quality measures and data sources that were not immediately feasible (IOM, 2001, p. 83, 2002). The Future Directions committee agrees that such development needs to occur, particularly in concert with consideration of measurement areas and their prioritization. Such investigation of future measure and data possibilities is less likely to happen without the investment of funds. Health insurance reform bills considered in the U.S. Congress in 2009 and early 2010 lodged the responsibility for funding the development of quality improvement measures with the HHS Secretary. The Senate version, which was signed into law in March 2010, specifically stipulates measure development is to be done in consultation with AHRQ, CMS, and NQF. 11 When existing health care quality measures and data sources are insufficient to track national progress in the identified national priority areas, AHRQ should directly or indirectly support the development of needed measures and the acquisition of relevant data sources. For report purposes, AHRQ tends to pay data use fees but does not pay for infrastructure development (e.g., data collection), partially because AHRQ has had limited funds avail - able for this purpose. As illustrated by the development of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys, there is precedent for AHRQ leadership when a demonstrated measurement need has not been filled elsewhere. The Centers for Disease Control and Prevention (CDC) develops critical data infrastructure needs through a granting process, an approach that AHRQ might consider for key areas determined to be a priority (for example, providing some support in selected states for all-payer claims databases; other developmental areas might include patient registries and all-patient databases derived from provider rather than insurance sources). 12 To date, AHRQ has lacked the resources to fully take advantage of public administrative data (e.g., Medicare and Medicaid data) or to obtain more timely data from existing report sources, so the benefit of developing new databases will need to be weighed against the benefit of more comprehensively using existing sources. The prin - 10 The scientist Lord Kelvin said, “When you can measure what you are speaking about, and express it in numbers, you know something about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a meager and unsatisfactory kind; it may be the beginning of knowledge, but you have scarcely in your thoughts advanced to the stage of science” (Thompson, 1889, p. 73). Later, this statement was abbreviated to “if you can measure it, you can manage it” and “if you cannot measure it, you cannot manage it;” these statements are often attributed to Peter Drucker. 11 Patient Protection and Affordable Care Act, Public Law 111-148 § 3013 and 3023, 111th Cong., 2d sess. (March 23, 2010). Quality measure development was also addressed in the Affordable Health Care for America Act, HR 3962 § 1442, 111th Cong., 1st sess. (November 7, 2009). 12 After the Future Directions committee concluded its deliberations, HHS announced its intent to build a universal claims database for health research; see https://www.fbo.gov/?s=opportunity&mode=form&id=71d119aea45a6f2efdc5862cac9cb6e2&tab=core&_cview=0 (accessed January 12, 2010).

OCR for page 137
 IMPLEMENTING RECOMMENDED CHANGES ciples for prioritizing the selection of quality measures discussed in Chapter 4 can also be used to prioritize areas for developing measures and data sources. The committee believes the development of additional data sources and sound quality measures in national priority areas for the national healthcare reports can be supported by all federal agencies that conduct research and collect health care-related data (e.g., AHRQ, CMS, CDC, the U.S. Department of Defense, the Department of Veterans Affairs, and the National Institutes of Health). Additionally, measure development is an important area for strategic partnerships, including, perhaps, jointly funded research with AHRQ’s non-federal partner organizations (e.g., NQF, the National Committee for Quality Assurance, The Joint Commission, the Physician Consortium for Performance Improvement convened by the American Medical Association, The Leapfrog Group, organizations representing communities of color). Regional consortia, academic institutions, health plans, and professional societies, among others, also play roles in measure development and adaptation, and a two-way interchange between these entities and AHRQ through the selection and prioritization process of the NAC Technical Advisory Subcommittee for Measure Selection would be beneficial. EVALUATION OF THE AHRQ REPORT-RELATED ENDEAVOR Along with its recommendation for an increase in financial support to AHRQ to facilitate transformation of the NHQR, NHDR, and their associated products, the Future Directions committee recommends a rigorous evaluation of the reports so that AHRQ can gain a better understanding of the reports’ contribution to quality improvement and disparities reduction. The committee recommends that AHRQ institute an explicit, ongoing program of internal and independent external evaluations of the national healthcare reports and associated products to: • Offer fresh perspectives on how the reports are being used to produce change. • Assess what types of analyses are most actionable. • Examine why AHRQ products may not be used by their targeted audiences. • Determine ways in which the reports could provide better and more actionable information. • Evaluate how the results associated with the products justify the investment in them. Regular, formal reviews of AHRQ’s portfolio of products should consider how to produce the most relevant information possible for policy makers, the public, and individuals and entities responsible for implementing quality improvement interventions, including organizations representing and serving communities of color. The committee does not want to convey the idea that just producing more fact sheets or other derivative products is an end in and of itself. The relevance of these various products should be assessed to assist AHRQ in determining priorities for the continuation of existing products or the development of future ones given available resources. Thus, Recommendation 10: AHRQ should regularly conduct an evaluation of its products to determine if they are meeting the needs of its target audiences and to assess the degree to which the information in the AHRQ products is leveraged to spur action on quality improvement and the elimination of disparities. TIMELINE FOR IMPLEMENTING RECOMMENDATIONS Although the IOM Future Directions committee recognizes that the transformation of the NHQR and NHDR and related products will not happen overnight, action steps can begin with the 2010 reports. The 2010 NHQR and NHDR are under development during calendar year 2010 and planned for release in early 2011. The committee’s suggested timeline for action steps is presented in Figure 7-1; any one step in the timeline could be performed earlier than suggested.

OCR for page 137
 Calendar Year 2012 Calendar Year 2010 Calendar Year 2011 AHRQ upgrades presentatio n aspects of NHQR, AHRQ continues to refine presentation ( NHQR, AHRQ continues refinements in presentation NHDR, and State Snapshots; begins consultation NHDR, State Snapshots, NHQRDRnet) by as recommended by experts with graphics and presentation experts consulting graphics, statistical, communication, (see Chapters 2 and 6 ) and technology /website experts AHRQ maps measure and data needs to national AHRQ incorporates new measures and data AHRQ incorporates new measures and data priority areas; incorporates available measures that suppor t priority areas as they become that suppor t priority areas; notes where (see Chapters 2 and 3 ) available either nationally or subnationally; measure and data needs remain notes where measure and data needs remain AHRQ plans for development of fact sheets and AHRQ begins developing NHQRDRnet capabili- AHRQ upgrades online presentation of other derivative products, and for expanded ties that allow users to customize reports NHQRDRnet to allow customization of reports dissemination and utilizatio n of fact sheets and derivative (see Chapter 6 ) AHRQ develops user guide on accessing products to suppor t data primar y data and how to apply findings in action AHRQ forms theTechnical Advisory Subcommittee Technical Advisory Subcommittee Technical Advisory Subcommittee for Measure Selection to NAC that - releases findings on relative rankings of its - releases additional findings on relative - plans for analysis of current core measures and current measures and on some additional ranking of quality measures additional measures for relative health care quality measures - continues analysis of measures as needed quality impact - recommends to NAC/AHRQ areas for funding - recommends to NAC/AHRQ areas for funding - issues call for suggested additions and deletions research on measures and data acquisition research on measures and data acquisition to core measure set - begins to identify measure and data gaps (see Chapter 4) AHRQ contracts for evaluation of current user AHRQ evaluates user groups’ application of AHRQ incorporates updates to the reports groups’ practices and how change would af fect report findings to affect change based on user group evaluations and the reports’ utility for these users reexamines effectiveness of dissemination (see Chapter 7) and partnership ef forts AHRQ seeks additional funding AHRQ continues to fund development and AHRQ funds development/evaluation of (see Chapter 7) evaluation of measures and data sources measures and data sources FIGURE 7-1 Suggested timeline for implementing recommended activities. Figure 7-1, duplicate of Figure S-2 R01677 editable vectors, landscape

OCR for page 137
 IMPLEMENTING RECOMMENDED CHANGES CONCLUSION The committee recognizes the excellent work that has been done by AHRQ with regard to the publication of the NHQR and NHDR despite some resource constraints. The committee believes that these reports can be made more forward-looking and action-oriented, offering diverse audiences a picture of what constitutes desired health care, where shortcomings in care now lie, and what policies and practices may spur overall improvement in U.S. health care quality and disparities elimination. Sufficient additional resources will be required to support the role that the committee envisions the NHQR and NHDR playing in the future of U.S. quality improvement efforts. REFERENCES CBO (Congressional Budget Office). 2007. The long-term outlook for health care spending. Washington, DC: Congressional Budget Office. CMS (Centers for Medicare and Medicaid Services). 2010. Historical national health expenditure data. http://www.cms.hhs.gov/NationalHeal- thExpendData/02_NationalHealthAccountsHistorical.asp#TopOfPage (accessed January 6, 2010). Cutler, D. M. 2009. Will the cost curve bend, even without reform? New England Journal of Medicine 361(15):1424-1425. Dean, N. C. 2009. The unintended, negative consequences of the door-to-antibiotic measure for pneumonia. Annals of Internal Medicine 150(3): 219. Fonarow, G. C., and E. D. Peterson. 2009. Heart failure performance measures and outcomes: Real or illusory gains. Journal of the American Medical Association 302(7):792-794. Fonarow, G. C., W. T. Abraham, N. M. Albert, W. G. Stough, M. Gheorghiade, B. H. Greenberg, C. M. O’Connor, K. Pieper, J. L. Sun, C. Yancy, and J. B. Young. 2007. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. Journal of the American Medical Association 297(1):61-70. IOM (Institute of Medicine). 2001. Enisioning the National Healthcare Quality Report. Washington, DC: National Academy Press. ———. 2002. Guidance for the National Healthcare Disparities Report. Washington, DC: The National Academies Press. ———. 2006. Performance measurement: Accelerating improement. Washington, DC: The National Academies Press. ———. 2008. Committee on Future Directions for the National Healthcare Quality and Disparities Reports: Statement of task. Washington, DC: Institute of Medicine. Keehan, S., A. Sisko, C. Truffer, S. Smith, C. Cowan, J. Poisal, M. K. Clemens, and the National Health Expenditure Accounts Projections Team. 2008. Health spending projections through 2017: The baby-boom generation is coming to Medicare. Health Affairs 27(2):w145-w155. Kfoury, A. G., T. K. French, B. D. Horne, K. D. Rasmusson, D. L. Lappé, H. L. Rimmasch, C. A. Roberts, R. S. Evans, J. B. Muhlestein, J. L. Anderson, and D. G. Renlund. 2008. Incremental survival benefit with adherence to standardized heart failure core measures: A perfor- mance evaluation study of 2,958 patients. Journal of Cardiac Failure 14(2):95-102. NQF (National Quality Forum). 2009. HHS awards NQF contract to expand priority-setting actiities and enhance its portfolio of standardized performance measures. http://qualityforum.org/News_And_Resources/Press_Releases/2009/HHS_Awards_NQF_Contract_to_Expand_ Priority-Setting_Activities_and_Enhance_its_Portfolio_of__Standardized_Performance_Measures.aspx (accessed December 2, 2009). Stand for Quality. 2009. Stand for quality in health care. http://standforquality.org/SFQ_Report_3_19_09.pdf (accessed December 2, 2009). Thompson, W. 1889. Electrical units of measurement. In Popular lectures and addresses. Vol. 1. London and New York: Macmillan and Co. Wachter, R. M., S. A. Flanders, C. Fee, and P. J. Pronovost. 2008. Public reporting of antibiotic timing in patients with pneumonia: Lessons from a flawed performance measure. Annals of Internal Medicine 149(1):29-32.

OCR for page 137